Pharmacotherapy in Addiction

Medication-assisted treatment supports recovery by reducing withdrawal symptoms and cravings. Different substances require distinct pharmacological interventions. Drugs like naltrexone, buprenorphine, and methadone modulate opioid receptors to reduce relapse risk. Pharmacotherapy is most effective when combined with behavioral therapy. Patient adherence is critical to avoid complications. Research continues to explore novel receptor-targeted therapies.

Therapeutic Medication Pathways:

      • Evidence for pharmacological agents
      • Patient-specific medication selection
      • Novel neuro-targeted therapeutics

    Related Conference of Pharmacotherapy in Addiction

    September 23-24, 2026

    6th Annual Congress on Mental Health

    Amsterdam, Netherlands
    October 19-20, 2026

    6thAnnual Congress on Mental Health & Psychiatry

    Paris, France
    October 26-27, 2026

    6th Annual Psychiatrists and Psychologists Meet

    Amsterdam, Netherlands
    October 26-27, 2026

    International Congress on Cognitive Psychotherapy

    Amsterdam, Netherlands
    January 28-29, 2027

    9th International Congress on Mental Health

    Singapore City, Singapore
    March 18-19, 2027

    34th World Psychiatrists and Psychologists Meet

    Berlin, Germany
    March 25-26, 2027

    8th Annual Congress on Psychiatry

    Paris, France
    May 19-20, 2027

    9th European Autism Congress

    Paris, France
    September 14-15, 2027

    5th World Congress on Psychiatry

    London, UK

    Pharmacotherapy in Addiction Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in